AHPA's monthly newsletter. Members log in to access issues of the AHPA Report.
The July 2021 AHPA Report includes:AHPA Webinar: Product Safety Surveillance with webPOISONCONTROL®; AHPA Board announces new Trustee; AHPA Botanical Congress now available on-demand; AHPA Guidance: Federal labeling requirements for herbal dietary supplements; and more!
The June 2021 AHPA Report includes: AHPA has released updates to the Botanical Safety Handbook; AHPA updates GACP-GMP guidance; AHPA updates Primer on CITES; and more!
The May 2021 AHPA Report includes: AHPA hires Glenn Christenson as Director of Communications & Marketing, AHPA Hemp Lexicon, AHPA 9th Botanical Congress; and more!; and more!
The April 2021 AHPA Report includes: AHPA Welcomes New Board Trustees & Officers; The 2011 – 2017 Tonnage survey of Select North American Wild-Harvested Plants has been released; AHPA 9th Botanical Congress; AHPA Board of Trustees takes action during March 2021 Meetings; AHPA Annual Member Meeting review; and more!
The March 2021 AHPA Report includes: AHPA Spring 2021 Meeting & Event Schedule; FDA Guidance Webinar; AHPA continues engagement with NIH’s National Center for Complementary and Integrative Health (NCCIH); and more!
The February 2021 AHPA Report includes: AHPA expands COVID Web Center; AHPA Annual Member Meeting; AHPA is hiring: Manager of Communications & Marketing; The US regulatory and legislative landscape in 2021 and beyond; and more!
The January 2021 AHPA Report includes: AHPA is hiring: Manager of Communications & Marketing; Noted physician touts nutrition’s critical role in supporting immune health for congressional staff; New safety information added to Botanical Safety Handbook; AHPA attends FDA public meetings clarifying proposed food traceability rule; AHPA attends Cosmetic Ingredients Review meeting.
The December 2020 AHPA Report includes: AHPA promotes Amber Bennett to new VP position; Ransomware Protection: How Safe is Your Data?; AHPA Webinar: Post-Election Download - Free and On-Demand; Call for candidates to AHPA's Board of Trustees; Nominations now being accepted for 2021 AHPA Awards and more.
The November 2020 AHPA Report includes: AHPA Sports Nutrition Congress: A Grand Slam!; AHPA has released updates via the online Botanical Safety Handbook 2nd ed.; AHPA Chief Science Officer Dr. Holly Johnson to present at Whole Plant Expo; FDA issues proposed rule for traceability on "certain foods"; and more.
The October 2020 AHPA Report includes: Inaugural Sports Nutrition Congress; Scientists step up to the plate at the AHPA Sports Nutrition Congress; The Vitamin Shoppe joins the AHPA Sports Nutrition Congress All-Star lineup!; AHPA President Michael McGuffin named to Nutritional Outlook Editorial Board; AHPA attends Cosmetic Ingredient Review meeting finalizing Scutellaria derived cosmetic ingredient safety reports; and more.
The September 2020 AHPA Report includes: Inaugural Sports Nutrition Congress; Hemp-CBD Supplement Congress now on-demand; 9th Annual Botanical Congress; AHPA seeks more time for small firms to comply with new labeling rules; Statement on oleandrin; Senator hoping for sensible guidance on CBD; Hemp-CBD market growth; and more.
The August 2020 AHPA Report includes: FDA announces resumption of domestic inspections; Daily consumption of certain cranberry products reduces risk of recurrent UTIs; Final guidance on BE labeling; Virtual Hemp-CBD Supplement Congress on Aug. 27; and more.
The July 2020 AHPA Report includes AHPA goes virtual, postal service funding request, sustainability webinar on July 22, updated CA Prop 65 guidance, revised CITES primer, FTC proposed rule for 'Made in the USA,' and more.
Since the first week of March, the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have been issuing warning letters alleging that marketers promoted a wide variety of products with claims to prevent, treat, mitigate, diagnose or cure COVID-19.
AHPA has analyzed 135 COVID-19 related warning letters issued by either FDA or FTC or by the agencies jointly between March 6, 2020, and May 11, 2020, and made available in each agency’s coronavirus information center as of May 15, 2020.
The June 2020 AHPA Report includes snapshots of global COVID-19 responses that impact the international supplement industry, FDA & FTC COVID-19 warning letters target social media and intravenous therapies, RFP for slippery elm sustainable wild harvest study, updated Hemp-CBD Status Report, and more.
2021 Annual Fund Sponsors
AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.